Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 2 9% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reaffirmed their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research note released on Tuesday, Benzinga reports. HC Wainwright currently has a $82.00 price objective on the stock. A number of other brokerages have also weighed in on APLS. UBS Group raised their target price on shares of […]
Apellis Pharmaceuticals (NASDAQ:APLS) Sees Unusually-High Trading Volume theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Candriam S.C.A. boosted its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 59.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 443,507 shares of the company’s stock after acquiring an additional 165,000 shares during the period. Candriam S.C.A. […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the fifteen brokerages that are presently covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy recommendation on […]